In order to reduce, if not completely suppress, late complications of combined chemotherapy and radiotherapy in Hodgkin's disease (HD), MOPP regimen (mechlorethamine, vincristine, procarbazine and prednisone) was replaced by ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Ninety-four ...
NEPA (netupitant+ palonosetron) Administration Is Safe and Effective in cHL Patients Receiving ABVD Regimen: A Single-Center Real Life Experience Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma, for which cyclophosphamide, doxorubicin, vincristine, and pred...
and several other western nations. Two hundred forty-six of 283 (87%) patients with HL from a University of Iowa/Mayo Clinic prospective observational database received ABVD as initial chemotherapy in 2003–present [15]. This regimen is also favored in densely populated but less prosperous countr...
Although the patients enrolled in this study are continuing to be observed for late toxicities, future studies evaluating this regimen will need to include long-term follow-up of larger cohorts. This study demonstrates the potential of using validated pharmacodynamic circulating cell death biomarkers to...